DNA Sequencing: Emerging Technologies and Applications
Report Highlights
The global market for sequencing products has grown to $5.9 billion in 2015 from $5.3 billion in 2014. The market is expected to grow at a five-year compound annual growth rate (CAGR) of 18.7% from 2015 to 2020, reaching nearly $13.8 billion by 2020.
Report Includes
- An in-depth analysis of the sequencing industry, an important industry in life sciences with enormous market potential.
- Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
- Quantification of the DNA sequencing markets by product type, platform, customer type, value chain position, analysis type and geography.
- A look at substantial future growth opportunities for industry participants including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.
- Comprehensive discussion covering sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives.
- A relevant patent analysis.
- Profiles of major players in the sequencing industry.
Report Scope
The scope of the report includes sequencing technologies, applications, industries, initiatives, markets, patents and companies. The markets for sequencing products and services are given for the years 2014, 2015 and 2020.
This report reviews the main sequencing platforms, and explains why genetic variation is important for many applications, including clinical testing. It then discusses some of the top research initiatives that are contributing to sequencing markets. Industry market driving forces are also discussed.
The report covers the sequencing markets by workflow, including sample preparation products; sequencing instruments and consumables; informatics; and sequencing services. It includes the sequencing instrument market by platform: Sanger and next-generation technologies, and by instrument class: low-throughput, high-throughput, benchtop and handheld.
The report covers the markets for the main sequencing end-use applications, including research (R&D, drug discovery and development, biotech); clinical; and applied (consumer, forensics, microbial genomics, agricultural genomics).
The report covers the sequencing clinical markets, including by test complexity, indication and test purpose. Test complexity refers to the multiplexing (e.g., the number of genes covered) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, sequencing instrument, informatics) will be in demand in the future.
The report provides market data and forecasts for sequencing-based diagnostics by specific applications, including those for cancer, rare diseases, common diseases, transplant and reproductive health.
The specific geographic markets discussed include North America, Europe, Asia-Pacific and the rest of the world.
Market data covers the years 2014, 2015 and 2020.
The report analyzes specific sequencing-related industries, including next-generation sequencing instruments (including market share data for the main instrument companies); droplet digital PCR; target enrichment and amplification; specialist DNA polymerase; noninvasive prenatal testing (including market share data for the leading companies); preimplantation genetic diagnosis and screening; liquid biopsy; immune sequencing; informatics industry; and human leukocyte antigen (HLA) typing industry.
More than 225 companies in the sequencing industry are profiled in this report.
BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2014 through early 2016, including key alliance trends.
Mr. Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with an emerging nanotechnology company. Mr. Bergin holds a BS degree in Chemistry, an MS degree in Biotechnology and a Masters of Business Administration.
Analyst Credentials
John Bergin has held business development, sales and marketing positions with a Fortune 500 advanced materials company, as well as executive management positions with a nanotechnology/separations company. Bergin holds a B.S. degree in Chemistry, an M.S. degree in Biotechnology and a Master of Business Administration. John Bergin is a pseudonym of the author.
- Synthetic Biology: Global Markets (BIO066F)
- Global DNA Read, Write and Edit Market (BIO193A)
- Global DNA Sequencing: Research, Applied and Clinical Markets (BIO045G)
- Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets (BIO150C)
- Genetic Modification Therapies Clinical Applications: Gene Therapies, Genetically Modified Cell Therapies, RNA Therapies and Gene Editing (BIO159A)
Report Highlights
The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.
Report Includes
- An overview of the global market for sequencing products and services.
- Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018.
- Quantification of the DNA sequencing markets by product type, platform, customer type,value chain position, analysis type and geography.
- A look at substantial future growth opportunities for industry participants including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments.
Report Highlights
The global market for sequencing products was nearly $3 billion in 2011, and it is forecast to grow at a compound annual growth rate (CAGR) of 17.5% to reach $6.6 billion by 2016.
Report Highlights
- The worldwide market for sequencing products will grow from an estimated $1.3 billion in 2010 to more than $3.3 billion by 2015, a compound annual growth rate (CAGR) of 20.5% over the next 5 years.
- Life-science research and drug discovery and development applications represent the two largest markets for DNA sequencing revenues, accounting for an estimated $920.1 million in 2010. These markets are forecast to grow at a compound annual growth rate (CAGR) of 13% to reach nearly $1.7 billion in 2015.
- Emerging applications, including personal genomics and clinical diagnostics, are forecast to account for $541.4 million by the year 2015, an increase from $15.5 million in 2010 representing a 103.5% compound annual growth rate (CAGR).
Report Highlights
- The global DNA sequencing industry was worth $794.1 million in 2007. This is expected to reach $862.5 million in 2008 and $1.7 billion in 2013, a compound annual growth rate (CAGR) of 14.7%./li>
- Research and drug discovery/development generated global revenues of $600.4 million in 2007. This is expected to increase to $640.6 million in 2008 and $1.0 billion in 2013, for a CAGR of 9.7%.
- Commercial applications were valued at $193.6 million in 2007 and an estimated $218.8 million in 2008. This segment should reach $426.1 million in 2013, a CAGR of 14.3%.
Report Highlights
- Projected sales for the worldwide DNA sequencing and proteomics markets are expected to rise at an AAGR (average annual growth rate) of 17.6% from $7.8 billion in 2004 to $17.5 billion in 2009.
- Drug discovery and healthcare currently are two of the largest market sectors, representing respectively, some 46% and 20% of revenues in 2004.
- The food and renewable resource sector will grow at a modest pace motivated by the production of genetically altered food products offering better nutritional benefits and lower product costs.
- The environment market sector has only begun to tap into the technology benefits and this basic research sector will grow given the possibility of new research fields that may emerge.